These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9142045)
1. Beta 2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. Todd RF; Petty HR J Lab Clin Med; 1997 May; 129(5):492-8. PubMed ID: 9142045 [TBL] [Abstract][Full Text] [Related]
2. VLA-4 (alpha(4)beta(1)) engagement defines a novel activation pathway for beta(2) integrin-dependent leukocyte adhesion involving the urokinase receptor. May AE; Neumann FJ; Schömig A; Preissner KT Blood; 2000 Jul; 96(2):506-13. PubMed ID: 10887112 [TBL] [Abstract][Full Text] [Related]
3. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185 [TBL] [Abstract][Full Text] [Related]
4. CD11/CD18 and CD14 share a common lipid A signaling pathway. Ingalls RR; Monks BG; Savedra R; Christ WJ; Delude RL; Medvedev AE; Espevik T; Golenbock DT J Immunol; 1998 Nov; 161(10):5413-20. PubMed ID: 9820516 [TBL] [Abstract][Full Text] [Related]
5. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. Cao D; Mizukami IF; Garni-Wagner BA; Kindzelskii AL; Todd RF; Boxer LA; Petty HR J Immunol; 1995 Feb; 154(4):1817-29. PubMed ID: 7836767 [TBL] [Abstract][Full Text] [Related]
6. Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. Xia Y; Borland G; Huang J; Mizukami IF; Petty HR; Todd RF; Ross GD J Immunol; 2002 Dec; 169(11):6417-26. PubMed ID: 12444150 [TBL] [Abstract][Full Text] [Related]
7. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells. Alfano M; Mariani SA; Elia C; Pardi R; Blasi F; Poli G Blood; 2009 Feb; 113(8):1699-709. PubMed ID: 18941116 [TBL] [Abstract][Full Text] [Related]
8. Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules. Stöckl J; Majdic O; Pickl WF; Rosenkranz A; Prager E; Gschwantler E; Knapp W J Immunol; 1995 May; 154(10):5452-63. PubMed ID: 7730647 [TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization. Kindzelskii AL; Laska ZO; Todd RF; Petty HR J Immunol; 1996 Jan; 156(1):297-309. PubMed ID: 8598477 [TBL] [Abstract][Full Text] [Related]
10. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T; Behrendt N; Ploug M Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652 [TBL] [Abstract][Full Text] [Related]
11. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. Xue W; Kindzelskii AL; Todd RF; Petty HR J Immunol; 1994 May; 152(9):4630-40. PubMed ID: 8157977 [TBL] [Abstract][Full Text] [Related]
12. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. Simon DI; Wei Y; Zhang L; Rao NK; Xu H; Chen Z; Liu Q; Rosenberg S; Chapman HA J Biol Chem; 2000 Apr; 275(14):10228-34. PubMed ID: 10744708 [TBL] [Abstract][Full Text] [Related]